In this episode, Amanda Brummitt sits down with Sury Gupta, Co-Founder and CTO of Trial IQ, to talk about bringing clinical research directly to the point of care. Sury shares how Trial IQ acts as an “enablement layer” that helps community practices and infusion centers become trial-ready sites by automating trial matching, patient identification, site readiness, and physician education.
We dig into Trial IQ’s new integration with WeInfuse and how it opens a new service line for infusion providers without disrupting their existing clinical operations. Sury explains how it works in plain terms: the customer success team builds a site profile of each center, an AI system matches the patient population and the center’s capabilities to active trials, and opportunities surface in a trial discovery dashboard showing the trial, sponsor, financials, and patient counts. Nothing moves without the practice’s opt-in, and patient data never leaves the platform. The integration also works in reverse, connecting trial patients to nearby infusion centers that have the right capabilities.
A few highlights from the conversation:
- Why infusion centers are one of the most underutilized and obvious places for clinical research, despite having skilled staff, the right infrastructure, and motivated patients.
- How the platform helps match patients with rare conditions to trials that would be nearly impossible to find manually.
- Why the platform is free to infusion centers: sponsors and CROs cover the cost, and participation can open a new service line for centers.
- What onboarding looks like, including a business associate agreement, a one-click data integration with WeInfuse, and a target turnaround of just a couple of weeks.
Whether you’re curious about clinical research or ready to add it as a service line, this conversation is a great place to start. If you’d like to learn more about becoming a trial-ready site, reach out to the Trial IQ team at info@trialiq.ai.
Guest Speakers:
Sury Gupta, Trial IQ Co-Founder and CTO
